Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Sutro Biopharma, Inc. Banner

Sutro Biopharma, Inc.

STRO Stock Analysis

Page title

Section title

About Sutro Biopharma, Inc.

Biotechnology
Healthcare

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials...

Sutro Biopharma, Inc. Key Metrics

Market Cap
$331M
52 Weeks Low
$2.01
52 Weeks High
$6.13
P/B
2.16x
P/E
-2.64x
P/S
1.96x

Upcoming Events

    STRO Analyst Forecasts

    ‌
    ‌

    STRO Financials

    STRO Income Statement Key Metrics

    • Revenue(TTM)169.36 M
    • Gross Profit(TTM)162.34 M
    • EBITDA(TTM)-102.65 M
    • Net Income(TTM)-124.45 M
    • EPS Diluted(TTM)-1.84

    Decode STRO's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    STRO earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of STRO (0.956) is higher than the average of its peers (-0.236).

    Net Profit Margin vs Peers

    Net profit margin ratio of STRO (-0.695) is higher than the average of its peers (-140.375).

    STRO Return on Equity

    See how efficiently STRO generates profit for it's shareholders.

    -71.36%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of STRO (-0.714) is lower than the average of its peers (0.911).

    Return on Equity Growth

    STRO's Return on Equity has grown significantly over the past 10 years, increasing by over 57.63%.

    STRO Revenue Growth

    See how STRO has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    STRO's revenue has grown significantly over the past 10 years, increasing by over 12.54%.